2003
DOI: 10.1136/heart.89.6.597
|View full text |Cite
|
Sign up to set email alerts
|

Microarray analysis: a novel research tool for cardiovascular scientists and physicians

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
38
0
1

Year Published

2003
2003
2012
2012

Publication Types

Select...
6
2

Relationship

0
8

Authors

Journals

citations
Cited by 66 publications
(39 citation statements)
references
References 80 publications
(55 reference statements)
0
38
0
1
Order By: Relevance
“…Changes in the multigene patterns of expression can provide further clues about responses in regulatory mechanisms (Napoli et al, 2003). Microg environments have been shown to elicit both up-or down-regulation of specific genes in a rather wide assay of cell types.…”
Section: Introductionmentioning
confidence: 99%
“…Changes in the multigene patterns of expression can provide further clues about responses in regulatory mechanisms (Napoli et al, 2003). Microg environments have been shown to elicit both up-or down-regulation of specific genes in a rather wide assay of cell types.…”
Section: Introductionmentioning
confidence: 99%
“…We have a long trust experience with genomics and microarray analysis (reviewed in refs. 23,24). Total RNAs were extracted using Trizol solution (Invitrogen) according to the manufacturer's instructions.…”
Section: Introductionmentioning
confidence: 99%
“…Briefly, 5 Ag of total RNAs from a pool of siRNAYY1-SaOs-2 clones were used to obtain labeled cDNA. The first-and second-strand cDNA synthesis was performed using the GeneChip One-Cycle cDNA Synthesis kit (Affymetrix), as described previously in detail (23,24). Labeled cRNA was prepared using the GeneChip IVT Labeling kit (Affymetrix) according to the manufacturer's instructions.…”
Section: Introductionmentioning
confidence: 99%
“…Gene expression data could offer a remarkable detailed patient phenotype that could be used to correctly classify patient populations as to their disease risk or response to therapies. In both cases, genomic data represent a means to distinguish between patients who are otherwise alike by classical clinical variables (Cook and Rosenzweig, 2002;Goldsmith and Dhanasekaran, 2004;Napoli et al, 2003). This is still a work in progress in cardiovascular medical research.…”
Section: Microarray Technologymentioning
confidence: 99%
“…If DNA defines the inherent genetic make up of a person, it is the transcription of the DNA into RNA (that could be translated into protein) that integrates the dynamic interaction of an individual with the environment. Consequently, microarrays provide us with an opportunity to measure mRNA abundance that correlate with a particular disease state, clinical outcome, or therapeutic response, giving us an unprecedented opportunity to investigate the genomic contribution to cardiovascular diseases (Cook and Rosenzweig, 2002;Goldsmith and Dhanasekaran, 2004;Napoli et al, 2003).…”
Section: Gene Expression Profilingmentioning
confidence: 99%